Skip to main content

Advanced or Metastatic Neuroendocrine Cancer SWOG S2012

Status: Open to Enrollment
Email Us To Enroll

Study Details

View study details on clinicaltrials.gov.

Locations

  • Sutter Health System Wide

Clinical Trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Evaluating Addition of the Immunotherapy Atezolizumab to Standard Chemo Trmt for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside Lung

Deepti Behl
Deepti Behl
Principal investigator
View Profile

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?